Compare HII & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HII | ELAN |
|---|---|---|
| Founded | 1886 | 1954 |
| Country | United States | United States |
| Employees | 44000 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.8B |
| IPO Year | 2010 | 2018 |
| Metric | HII | ELAN |
|---|---|---|
| Price | $287.82 | $24.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $411.33 | $27.89 |
| AVG Volume (30 Days) | 464.3K | ★ 4.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 10.24 | N/A |
| EPS | ★ 3.79 | 0.11 |
| Revenue | ★ $12,484,000,000.00 | $4,715,000,000.00 |
| Revenue This Year | $4.82 | $8.21 |
| Revenue Next Year | $6.28 | $5.31 |
| P/E Ratio | ★ $77.42 | $228.95 |
| Revenue Growth | ★ 8.23 | 6.22 |
| 52 Week Low | $250.91 | $13.39 |
| 52 Week High | $460.00 | $27.72 |
| Indicator | HII | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 55.24 |
| Support Level | $287.43 | $22.33 |
| Resistance Level | $293.78 | $25.58 |
| Average True Range (ATR) | 8.03 | 0.84 |
| MACD | 2.62 | 0.04 |
| Stochastic Oscillator | 46.51 | 73.54 |
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.